Two pandemics - COVID-19 and obesity - are on a collision course. Individuals with obesity face a higher risk for adverse outcomes of COVID-19, and home quarantining measures have also exacerbated factors that predispose to obesity.
In this brand new SCOPE module, Dr Donna Ryan discusses the links between obesity and COVID-19 and the underlying biologic mechanisms of this association, and outlines management strategies to provide effective treatment to patients with obesity during the COVID-19 pandemic. This is an essential resource for all healthcare professionals treating obesity during this unprecedented global crisis.
Like most SCOPE modules, the course can be accessed completely free of charge via the SCOPE E-Learning platform. By completing the module, you will earn 0.5 SCOPE points which count towards your SCOPE Certification or annual renewal.
As the body of scientific knowledge around COVID-19 is constantly evolving, this module will be updated in early 2021 to incorporate any new research that emerges in the interim period. The course, which is currently available in English only, will then be translated to additional languages.
Watch Dr Donna Ryan talk about her Obesity and COVID-19 module!
Donna H. Ryan, MD is Professor Emerita at Pennington Biomedical in Baton Rouge, LA, where she directed clinical research for 22 years. Her own research includes participation on the teams that developed and executed the DASH (Dietary Approaches to Stop Hypertension), POUNDS Lost, DPP (Diabetes Prevention Program) and Look AHEAD Studies. Dr. Ryan’s continuing research interests focus on translation of effective weight management into primary care practices.
Dr. Ryan’s scholarly activities include authorship of more than 200 original publications and 45 books, chapters and reviews, primarily in the field of obesity. She is Associate Editor-in-Chief or Obesity. She served as co-Chair of the Expert Panel that produced the AHA/ACC/TOS 2013 Guidelines for the Diagnosis and Management of Obesity and was a panel member of the 2015 Endocrine Society Systematic Evidence Review and Guidelines for Medications that Affect Body Weight.
Dr. Ryan is Past President of the World Obesity Federation.
What is SCOPE?
SCOPE provides the only internationally-recognised certification in obesity management. The web-based SCOPE E-Learning platform offers more than 40 bitesize modules on obesity and its comorbidities, most of which are completely free to access.Discover SCOPE